Therapeutic Application of Alpha-1 Antitrypsin in COVID-19

被引：27
|
作者：
Krueger, Nadine [1 ]
Hoffmann, Markus [1 ,2 ]
Zuo, Wei [3 ]
Lammert, Frank [4 ,5 ]
Smola, Sigrun [6 ]
Tov, Naveh [7 ]
Alagem, Noga [7 ]
Lepper, Philipp M. [4 ]
Poehlmann, Stefan [1 ,2 ]
Beisswenger, Christoph [4 ]
Bals, Robert [4 ]
机构：
[1] Leibniz Inst Primate Res, German Primate Ctr, Gottingen, Germany
[2] Univ Gottingen, Gottingen, Germany
[3] Tongji Univ, Shanghai, Peoples R China
[4] Saarland Univ, Homburg, Germany
[5] Hannover Med Sch, Hannover, Germany
[6] Saarland Univ, Med Ctr, Homburg, Germany
[7] Kamada Ltd, Rehovot, Israel
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2021年 / 204卷 / 02期
关键词：
TMPRSS2;
D O I：
10.1164/rccm.202104-0833LE
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：224 / 227
页数：4
相关论文
共 50 条
  • [1] Alpha-1 Antitrypsin Deficiency and COVID-19 Infection
    Strassmair, Michael
    Stangl, Manfred
    [J]. ARCHIVOS DE BRONCONEUMOLOGIA, 2021, 57 : 97 - 97
  • [2] Alpha-1 antitrypsin deficiency severity and the risk of COVID-19
    Faria, Nuno
    Costa, Maria Ines
    Gomes, Joana
    Sucena, Maria
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [3] COVID-19 Vaccination for Patients with Severe Alpha-1 Antitrypsin Deficiency
    Mcelvaney, O.
    Fraughen, D.
    Kelly, G.
    Mcelvaney, O. F.
    Herron, M.
    Murphy, M. P.
    Carroll, T. P.
    Mcelvaney, N. G.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
  • [4] Safety and Reactogenicity of COVID-19 Vaccination in Severe Alpha-1 Antitrypsin Deficiency
    Mcelvaney, Oliver J.
    Cleary, Brian
    Fraughen, Daniel D.
    Kelly, Geraldine
    Mcelvaney, Oisin F.
    Murphy, Mark P.
    Branagan, Peter
    Gunaratnam, Cedric
    Carroll, Tomas P.
    Goss, Christopher H.
    Mcelvaney, Noel G.
    [J]. CHRONIC OBSTRUCTIVE PULMONARY DISEASES-JOURNAL OF THE COPD FOUNDATION, 2024, 11 (01): : 3 - 12
  • [5] Assessing The Impact of COVID-19 in Severe Alpha-1 Antitrypsin Deficiency (AATD)
    McGoldrick, K.
    Fraughen, D.
    Kelly, G.
    McElvaney, N. G.
    Carroll, T. P.
    [J]. IRISH JOURNAL OF MEDICAL SCIENCE, 2021, 190 (SUPPL 5) : 208 - 208
  • [6] Alpha-1 antitrypsin deficiency severity and the risk of COVID-19: A Portuguese cohort
    Faria, Nuno
    Costa, Maria Ines
    Gomes, Joana
    Sucena, Maria
    [J]. RESPIRATORY MEDICINE, 2021, 181
  • [7] INTRAVENOUS ALPHA-1 ANTITRYPSIN FOR CYTOKINEMIC COVID-19 COMPLICATING CYSTIC FIBROSIS
    O'Connor, E.
    McElvaney, O. J.
    McEvoy, N.
    Fraughan, D.
    McElvaney, O.
    Clarke, J.
    Gunaratnam, C.
    O'Rourke, J.
    Curley, G.
    McElvaney, G.
    [J]. PEDIATRIC PULMONOLOGY, 2020, 55 : S223 - S224
  • [8] Safety and Efficacy of COVID-19 Vaccination in Severe Alpha-1 Antitrypsin Deficiency
    Mcelvaney, O.
    Cleary, B.
    Mcelvaney, O. F.
    Fraughen, D. D.
    Kelly, G.
    Murphy, M. P.
    Branagan, P.
    Gunaratnam, C.
    Carroll, T. P.
    Mcelvaney, N. G.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [9] Alpha-1 antitrypsin for cystic fibrosis complicated by severe cytokinemic COVID-19
    McElvaney, Oliver J.
    O'Connor, Eoin
    McEvoy, Natalie L.
    Fraughan, Daniel D.
    Clarke, Jennifer
    McElvaney, Oisin F.
    Gunaratnam, Cedric
    O'Rourke, James
    Curley, Gerard F.
    McElvaney, Noel G.
    [J]. JOURNAL OF CYSTIC FIBROSIS, 2021, 20 (01) : 31 - 35
  • [10] Intravenous Alpha-1 Antitrypsin Therapy for Critically Ill COVID-19 Patients
    Wand, Ori
    Dahan, David
    Tov, Naveh
    Shochet, Gali Epstein
    King, Daniel A.
    Shitrit, David
    [J]. ISRAEL MEDICAL ASSOCIATION JOURNAL, 2022, 24 (07): : 441 - 443
12345